Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Upstaging and Lymph Node Metastasis Rate in Patients With Ductal Carcinoma in Situ Who Received Mastectomy Regarding the Necessary of Sentinel Lymph Node Biopsy

NCT05961280 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT05961280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05961280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Upstaging and Lymph Node Metastasis Rate in Patients With Ductal Carcinoma in Situ Who Received Mastectomy Regarding the Necessary of Sentinel Lymph Node Biopsy
Lead sponsor
Gangnam Severance Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2010
Completion date
December 30, 2021
Enrollment
385 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ductal carcinoma in situ